Nektar Therapeutics (NKTR)
1.645
-0.02
(-0.90%)
USD |
NASDAQ |
May 24, 15:43
Nektar Therapeutics Cash and Short Term Investments (Quarterly): 289.24M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 289.24M |
December 31, 2023 | 303.62M |
September 30, 2023 | 372.66M |
June 30, 2023 | 409.43M |
March 31, 2023 | 456.83M |
December 31, 2022 | 504.98M |
September 30, 2022 | 546.39M |
June 30, 2022 | 619.32M |
March 31, 2022 | 667.02M |
December 31, 2021 | 733.96M |
September 30, 2021 | 921.08M |
June 30, 2021 | 1.000B |
March 31, 2021 | 1.037B |
December 31, 2020 | 1.062B |
September 30, 2020 | 956.01M |
June 30, 2020 | 1.038B |
March 31, 2020 | 1.346B |
December 31, 2019 | 1.325B |
September 30, 2019 | 1.496B |
June 30, 2019 | 1.515B |
March 31, 2019 | 1.389B |
December 31, 2018 | 1.335B |
September 30, 2018 | 1.420B |
June 30, 2018 | 1.824B |
March 31, 2018 | 296.66M |
Date | Value |
---|---|
December 31, 2017 | 296.13M |
September 30, 2017 | 352.57M |
June 30, 2017 | 265.55M |
March 31, 2017 | 358.52M |
December 31, 2016 | 389.10M |
September 30, 2016 | 253.51M |
June 30, 2016 | 274.85M |
March 31, 2016 | 288.32M |
December 31, 2015 | 308.94M |
September 30, 2015 | 267.82M |
June 30, 2015 | 254.66M |
March 31, 2015 | 300.80M |
December 31, 2014 | 237.82M |
September 30, 2014 | 236.64M |
June 30, 2014 | 276.44M |
March 31, 2014 | 284.07M |
December 31, 2013 | 237.03M |
September 30, 2013 | 183.55M |
June 30, 2013 | 201.88M |
March 31, 2013 | 236.20M |
December 31, 2012 | 277.19M |
September 30, 2012 | 319.28M |
June 30, 2012 | 432.87M |
March 31, 2012 | 382.11M |
December 31, 2011 | 241.17M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
289.24M
Minimum
Mar 2024
1.515B
Maximum
Jun 2019
830.00M
Average
827.52M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Stereotaxis Inc | 17.63M |
Vanda Pharmaceuticals Inc | 394.14M |
Cara Therapeutics Inc | 69.77M |
Avid Bioservices Inc | 30.71M |
Rigel Pharmaceuticals Inc | 49.55M |